EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel insights into Hodgkin lymphoma biology by single-cell analysis

Tomohiro Aoki iD, Christian Steidl iD

Blood · 13.04.2023 · 141 (15) · 1791-1801

DOI: 10.1182/blood.2022017147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, erschienen am 13.04.2023. Verfasst von Tomohiro Aoki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Hodgkin Disease. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence and rapid development of single-cell technologies mark a paradigm shift in cancer research. Various technology implementations represent powerful tools to understand cellular heterogeneity, identify minor cell populations that were previously hard to detect and define, and make inferences about cell-to-cell interactions at single-cell resolution. Applied to lymphoma, recent advances in single-cell RNA sequencing have broadened opportunities to delineate previously underappreciated heterogeneity of malignant cell differentiation states and presumed cell of origin, and to describe the composition and cellular subsets in the ecosystem of the tumor microenvironment (TME). Clinical deployment of an expanding armamentarium of immunotherapy options that rely on targets and immune cell interactions in the TME emphasizes the requirement for a deeper understanding of immune biology in lymphoma. In particular, classic Hodgkin lymphoma (CHL) can serve as a study paradigm because of its unique TME, featuring infrequent tumor cells among numerous nonmalignant immune cells with significant interpatient and intrapatient variability. Synergistic to advances in single-cell sequencing, multiplexed imaging techniques have added a new dimension to describing cellular cross talk in various lymphoma entities. Here, we comprehensively review recent progress using novel single-cell technologies with an emphasis on the TME biology of CHL as an application field. The described technologies, which are applicable to peripheral blood, fresh tissues, and formalin-fixed samples, hold the promise to accelerate biomarker discovery for novel immunotherapeutic approaches and to serve as future assay platforms for biomarker-informed treatment selection, including immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseHumansEcosystemTumor MicroenvironmentSingle-Cell AnalysisBiology

Autor:innen und Institutionen

  • Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

ORCID-Profile: Tomohiro Aoki, Christian Steidl

Zitieren

APA

Aoki, T., & Steidl, C. (2023). Novel insights into Hodgkin lymphoma biology by single-cell analysis. Blood, 141(15), 1791-1801. https://doi.org/10.1182/blood.2022017147

Vancouver

Aoki T, Steidl C. Novel insights into Hodgkin lymphoma biology by single-cell analysis. Blood. 2023;141(15):1791-1801. doi:10.1182/blood.2022017147

BibTeX
@article{Aoki2023,
  author = {Aoki, Tomohiro and Steidl, Christian},
  title = {Novel insights into Hodgkin lymphoma biology by single-cell analysis},
  journal = {Blood},
  year = {2023},
  volume = {141},
  number = {15},
  pages = {1791--1801},
  doi = {10.1182/blood.2022017147}
}
Kostenlos starten →